Literature DB >> 2828005

Effects of the administration of phosphate on nuclear 1,25-dihydroxyvitamin D3 uptake by duodenal mucosal cells of Hyp mice.

T Yamamoto1, Y Seino, H Tanaka, K Yamaoka, H Kurose, M Ishida, H Yabuuchi.   

Abstract

Effects of the administration of phosphate on nuclear 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] uptake by duodenal mucosal cells of Hyp mice were investigated. In Hyp mice fed a high phosphate diet (1.1% Ca and 2.0% phosphate) for 2 weeks, maximal nuclear 1,25-(OH)2D3 binding by duodenal mucosal cells is significantly increased from 5.01 +/- 0.49 x 10(3) to 8.23 +/- 1.10 x 10(3) sites/cell (P less than 0.05). No significant change was observed in normal mice fed the same diet. The serum phosphate concentration of Hyp mice increased significantly (P less than 0.01), whereas no significant change was found in normal mice. On this regimen, serum calcium, urinary cAMP to creatinine ratio, and cytosolic 1,25-(OH)2D3 receptor number in Hyp mice were not changed significantly. On the basis of these data, we speculate that the recovery of serum phosphate in Hyp mice fed a high phosphate diet affects the recovery of nuclear 1,25-(OH)2D3 uptake by duodenal mucosal cells. The mechanism for this recovery is not related to either the secondary hyperparathyroidism or the change in cytosolic 1,25-(OH)2D3 receptor content but, rather, to increased binding of 1,25-(OH)2D3-receptor complex to nuclei. Hypophosphatemia, therefore, appears to play a role in the vitamin D resistance in Hyp mice.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2828005     DOI: 10.1210/endo-122-2-576

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  2 in total

1.  Response of jejunal phosphate absorption to 1,25-dihydroxyvitamin D(3) stimulationin vivo in young X-linked hypophosphatemic (Hyp) mice.

Authors:  R A Meyer; M H Meyer; R W Gray; B A Brault
Journal:  Endocrine       Date:  1995-03       Impact factor: 3.633

2.  Serum calcitriol levels in a patient with X-linked hypophosphatemia complicated by autosomal dominant polycystic kidney disease.

Authors:  Satomi Kajita; Takehisa Yamamoto; Naoko Tsugawa; Hirohumi Nakayama; Takuo Kubota; Toshimi Michigami; Keiichi Ozono
Journal:  CEN Case Rep       Date:  2016-10-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.